Privium Fund Management’s Bionano Genomics, Inc. Warrant BNGOW Stock Holding History

Privium Fund Management’s Portfolio BNGOW Stock Details BNGOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-74,564	Closed	-$22K	–	262
2022 Q2	$22K	Sell	74,564 -6,205	-8%	-$2.51K	0.01%	154
2022 Q1	$53K	Sell	80,769 -21,905	-21%	-$17.8K	0.01%	170
2021 Q4	$121K	Buy	+102,674	New	+$175K	0.02%	125

Other funds holding BNGOW

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Privium Fund Management's BNGOW Position: Q3 2022 in Review

Privium Fund Management sold out of Bionano Genomics, Inc. Warrant (BNGOW) in Q3 2022, closing a stake of 74,564 shares — an estimated $22K sold.

Privium Fund Management first reported a position in BNGOW in Q4 2021 and held it in 3 quarters. The position peaked at $121K in Q4 2021. 2 funds tracked by Wall St. Rank hold BNGOW as of Q3 2022.

Privium Fund Management reported no remaining Bionano Genomics, Inc. Warrant position as of Q3 2022 after selling out during the quarter.
Privium Fund Management sold 74,564 Bionano Genomics, Inc. Warrant shares in Q3 2022, an estimated $22K.
Privium Fund Management first reported a position in Bionano Genomics, Inc. Warrant in Q4 2021 and held it in 3 quarters.
Privium Fund Management's Bionano Genomics, Inc. Warrant position peaked at $121K in Q4 2021.
2 funds tracked by Wall St. Rank held Bionano Genomics, Inc. Warrant as of Q3 2022.

Based on Privium Fund Management's 13F filing for Q3 2022, filed 3 Nov 2022.